Quince Therapeutics, Inc. Common Stock (QNCX) News

Latest headlines that mention QNCX, newest first · each headline opens the original publisher

QNCX quote

Last price: $31.73
Day change: +8.07%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

QNCX headlines

latest coverage

Investing.com 18d ago

Raymond James initiates Quince Therapeutics stock coverage with outperform rating

General T3QNCX RJF

Seeking Alpha News 20d ago

Quince Therapeutics, Inc. (QNCX) Shareholder/Analyst Call Prepared Remarks Transcript

General T2QNCX

Seeking Alpha News 28d ago

Quince Therapeutics, Inc. (QNCX) Discusses LAM-001 Clinical Progress in Pulmonary Hypertension and Bronchiolitis Obliterans Syndrome Transcript

General T2QNCX

Investing.com 1mo ago

Rodman & Renshaw initiates Quince Therapeutics stock with buy rating

General T3QNCX

Seeking Alpha 2mo ago

Quince Therapeutics GAAP EPS of -$12.31 misses by $0.02

Earnings T2QNCX

Investing.com 2mo ago

Form PRE 14A Quince Therapeutics Inc For: 1 August

General T3QNCX

Investing.com 2mo ago

Form S-3 Quince Therapeutics For: 31 July

General T3QNCX

Investing.com 4mo ago

Cantor Fitzgerald reiterates Quince Therapeutics stock Overweight rating

General T3QNCX

Investing.com 4mo ago

Form 4 Quince Therapeutics Inc For: 15 June

General T3QNCX

Seeking Alpha News 4mo ago

Quince Therapeutics, Inc. (QNCX) Shareholder/Analyst Call Prepared Remarks Transcript

General T2QNCX

Investing.com 5mo ago

Quince Therapeutics regains compliance with Nasdaq listing requirements

Markets T3QNCX

Seeking Alpha News 5mo ago

Quince Therapeutics, Inc. (QNCX) OrphAI Therapeutics Inc - M&A Call - Slideshow

General T2QNCX

Seeking Alpha News 5mo ago

Quince Therapeutics, Inc. (QNCX) M&A Call Prepared Remarks Transcript

General T2QNCX

Also mentioned with QNCX

30d

RJF1

Headlines that tag both tickers

QNCX news alerts

Get an alert by email or push when a new headline mentions QNCX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.